M

Mohamed A. Gouda

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0003-4829-6739

Publishes on Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Sarcoma Diagnosis and Treatment. 171 papers and 1.2k citations.

171Publications

1.2kTotal Citations

First publication: 2006First senior author: 2016

Cancer Genomics and Diagnostics Lung Cancer Treatments and Mutations Sarcoma Diagnosis and Treatment Radiomics and Machine Learning in Medical Imaging Colorectal Cancer Treatments and Studies

Top publicationsby citations

Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)

Mohamed A. Gouda, Vivek Subbiah, Filip Jankú et al.|Annals of Oncology|2023

Cited by 103

Precision oncology for BRAF-mutant cancers with BRAF and MEK inhibitors: from melanoma to tissue-agnostic therapy

Mohamed A. Gouda, Vivek Subbiah|ESMO Open|2023

Cited by 101

Expanding the Benefit: Dabrafenib/Trametinib as Tissue-Agnostic Therapy for <i>BRAF</i> V600E–Positive Adult and Pediatric Solid Tumors

Mohamed A. Gouda, Vivek Subbiah|American Society of Clinical Oncology Educational Book|2023

Cited by 92

ALK fusions in the pan-cancer setting: another tumor-agnostic target?

Aditya Shreenivas, Razelle Kurzrock, Filip Jankú et al.|npj Precision Oncology|2023

Cited by 89

The evolving landscape of tissue‐agnostic therapies in precision oncology

Vivek Subbiah, Razelle Kurzrock, Mohamed A. Gouda et al.|CA A Cancer Journal for Clinicians|2024

Cited by 68